STERIS’ (TSE:STE – Free Report) – Analysts at Raymond James decreased their FY2026 earnings estimates for shares of STERIS’ in a report issued on Tuesday, October 15th. Raymond James analyst M. Barth now expects that the company will post earnings per share of $0.67 for the year, down from their previous estimate of $0.74.
STERIS’ (TSE:STE – Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported C$0.14 earnings per share for the quarter, beating the consensus estimate of C$0.12 by C$0.02. The business had revenue of C$231.38 million for the quarter, compared to the consensus estimate of C$226.20 million.
STERIS’ Price Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Should Warren Buffett’s Favorite Stock be Yours Too?
- What is a Death Cross in Stocks?
- Why Buffett Loves Occidental Stock And What It Means for Chevron
- 3 Grocery Stocks That Are Proving They Are Still Essential
- UnitedHealth Group Pulls Back Into a Healthy Buying Opportunity
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
